SCHEMBL28057133

SCHEMBL28057133

C1=CC(C2CCCC2)=NN=NN1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5600586 0.66 MAOA (0.30)
SCHEMBL5601989 0.64 CYP11B2 (0.31)
SCHEMBL5603253 0.64 CYP11B2 (0.31)
SCHEMBL5601065 0.64 CYP11B2 (0.31)
SCHEMBL2766035 0.64 CYP11B2 (0.31)
SCHEMBL5601700 0.64 CYP11B2 (0.31)
SCHEMBL5601697 0.61
SCHEMBL6379009 0.54 NISCH (0.32)
SCHEMBL7853833 0.53 TDO2 (0.32)
SCHEMBL7845159 0.52 CYP11B2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102791715-B As the tricyclic compound of kinase inhibitor FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III (ES) 2016-04-27 CN claimed
CN-104684912-A Inhibitor compounds of phosphodiesterase type 10A ABBVIE DEUTSCHLAND 2015-06-03 CN claimed
CN-103547580-A Substituted fused tricyclic compounds, compositions and medical uses thereof ADVINUS THERAPEUTICS LTD 2014-01-29 CN claimed
CN-102791715-B As the tricyclic compound of kinase inhibitor FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III (ES) 2016-04-27 CN disclosed
CN-102574845-B 1H-imidazo [4,5-c] qualone derivative NOVARTIS AG (CH) 2015-09-02 CN disclosed
CN-104684912-A Inhibitor compounds of phosphodiesterase type 10A ABBVIE DEUTSCHLAND 2015-06-03 CN disclosed
CN-103547580-A Substituted fused tricyclic compounds, compositions and medical uses thereof ADVINUS THERAPEUTICS LTD 2014-01-29 CN disclosed